STOCK TITAN

EDAP TMS (EDAP) CEO awarded major RSU and stock option grants

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

EDAP TMS SA reported that Chief Executive Officer Ryan Rhodes received new equity compensation. On May 12, 2026, he was granted 304,500 restricted stock units (RSUs), which will vest over four years starting on the second anniversary of the grant date.

On the same date, he was also granted 390,000 stock options exercisable for EDAP common stock at an exercise price of $4.17 per share, with vesting beginning six months after the grant date and continuing monthly through the third anniversary. Following these grants, his direct holdings of EDAP common stock totaled 605,649 shares.

Positive

  • None.

Negative

  • None.
Insider Rhodes Ryan
Role Chief Executive Officer
Type Security Shares Price Value
Grant/Award Stock Options 390,000 $0.00 --
Grant/Award Common Stock 304,500 $0.00 --
Holdings After Transaction: Stock Options — 390,000 shares (Direct, null); Common Stock — 605,649 shares (Direct, null)
Footnotes (1)
  1. Common Stock for the issuer refers to the issuer's ordinary shares. Represents restricted stock units ("RSUs") granted pursuant to the 2025-2 Restricted Stock Unit (Free Share) Plan of the issuer on May 12, 2026, one-half of which will vest on the second anniversary of the date of grant and the remaining one-half will vest in equal installments every 6 months thereafter through the fourth anniversary of the date of grant. Each RSU represents the right to receive one share of EDAP common stock upon settlement. The option exercise price reflected was converted from 3.54 euros to U.S. dollars based on an exchange rate of EUR 1 to USD 1.1784. The options, which were granted on May 12, 2026, will become exercisable with respect to one-sixth of the options on the six-month anniversary of the date of grant and the remaining five-sixths of the options will become exercisable on a monthly basis thereafter through the third anniversary of the date of grant.
RSUs granted 304,500 RSUs Granted to CEO on May 12, 2026 under 2025-2 RSU Plan
Options granted 390,000 options CEO stock options granted on May 12, 2026
Option exercise price $4.17 per share Converted from 3.54 euros using EUR 1 = USD 1.1784
Option expiration May 12, 2036 Expiration date of CEO’s 390,000 stock options
Shares underlying options 390,000 shares Common stock issuable upon exercise of options
Shares held after RSU grant 605,649 shares CEO direct common stock ownership following RSU award
restricted stock units ("RSUs") financial
"Represents restricted stock units ("RSUs") granted pursuant to the 2025-2 Restricted Stock Unit (Free Share) Plan"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
2025-2 Restricted Stock Unit (Free Share) Plan financial
"granted pursuant to the 2025-2 Restricted Stock Unit (Free Share) Plan of the issuer on May 12, 2026"
option exercise price financial
"The option exercise price reflected was converted from 3.54 euros to U.S. dollars"
exercise date financial
"will become exercisable with respect to one-sixth of the options on the six-month anniversary of the date of grant"
expiration date financial
"expiration_date: "2036-05-12T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Rhodes Ryan

(Last)(First)(Middle)
4410 EL CAMINO REAL
SUITE 150

(Street)
LOS ALTOS, CALIFORNIA 94022

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
EDAP TMS SA [ EDAP ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
Chief Executive Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/12/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock(1)(2)05/12/2026A304,500A$0605,649D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Options$4.17(3)05/12/2026A390,000 (4)05/12/2036Common Stock390,000$0390,000D
Explanation of Responses:
1. Common Stock for the issuer refers to the issuer's ordinary shares.
2. Represents restricted stock units ("RSUs") granted pursuant to the 2025-2 Restricted Stock Unit (Free Share) Plan of the issuer on May 12, 2026, one-half of which will vest on the second anniversary of the date of grant and the remaining one-half will vest in equal installments every 6 months thereafter through the fourth anniversary of the date of grant. Each RSU represents the right to receive one share of EDAP common stock upon settlement.
3. The option exercise price reflected was converted from 3.54 euros to U.S. dollars based on an exchange rate of EUR 1 to USD 1.1784.
4. The options, which were granted on May 12, 2026, will become exercisable with respect to one-sixth of the options on the six-month anniversary of the date of grant and the remaining five-sixths of the options will become exercisable on a monthly basis thereafter through the third anniversary of the date of grant.
/s/ Blandine Confort, as Attorney-in-Fact05/13/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What equity awards did EDAP (EDAP) CEO Ryan Rhodes receive?

Ryan Rhodes received 304,500 RSUs and 390,000 stock options as equity compensation. The RSUs and options vest over multi-year schedules, aligning his incentives with EDAP’s long-term performance and increasing his exposure to the company’s common stock.

How do the new RSUs for EDAP (EDAP) CEO vest over time?

The 304,500 RSUs vest in stages over four years. One-half vests on the second anniversary of the May 12, 2026 grant, and the remaining half vests in equal installments every six months through the fourth anniversary, subject to the plan’s terms.

What are the key terms of the new EDAP (EDAP) stock options?

The CEO received 390,000 stock options exercisable for EDAP common stock at an exercise price of $4.17 per share. These options start vesting six months after May 12, 2026 and then vest monthly, becoming fully exercisable by the third anniversary.

How many EDAP (EDAP) shares does the CEO hold after these grants?

After the May 12, 2026 RSU grant, Ryan Rhodes holds 605,649 EDAP common shares directly. This figure reflects his reported ownership following the award and illustrates the scale of his equity stake in the company.

What plan governs the new RSUs granted to EDAP (EDAP) CEO?

The 304,500 RSUs were granted under EDAP’s 2025-2 Restricted Stock Unit (Free Share) Plan. Each RSU entitles the CEO to receive one share of EDAP common stock upon settlement, subject to the plan’s vesting schedule and other conditions.

When do the newly granted EDAP (EDAP) options expire?

The 390,000 stock options granted to the CEO on May 12, 2026 expire on May 12, 2036. He can exercise vested options any time before this expiration date, consistent with the vesting schedule and the option agreement’s terms.